Michael G Hanna

Professor Michael G Hanna is a Clinical Professor in the Department of Neuromuscular Diseases at University College London, where he serves as Director of the UCL Queen Square Institute of Neurology (2012–present) and leads a major capital project for a new building opening in 2027. He is also an Adjunct Professor at the University of Iowa and Honorary Professor at the University of Newcastle upon Tyne.

• Doctor of Medicine (University of Manchester, 1996)
• Honors Bachelor of Medicine & Surgery (University of Manchester, 1988)
• BSc in Medical Biochemistry (University of Manchester, 1986)

His research focuses on mitochondrial neuromuscular diseases and neurological channelopathies, with over 450 peer-reviewed articles and £40M secured for research. Key themes include genetic mechanisms in neurological disorders, mitochondrial DNA mutations, and muscle degeneration in acquired diseases. Recent publications highlight mitochondrial genetics, CNV reanalysis, and translational neuroscience.

• NIHR Senior Investigator (2022–present)
• Fellow of the UK Academy of Medical Sciences (2019–present)
• Goulstonian Lectureship (2003)
• Dorothy Clarke Memorial Prize (1998)

As a clinically active Consultant Neurologist at the National Hospital for Neurology and Neurosurgery (Queen Square), he has assessed over 50,000 patients and co-leads a world-leading neuromuscular disease center. His leadership roles include Director of the MRC International Centre for Genomic Medicine in Neuromuscular Diseases (2022–present) and former Director of the MRC Centre for Neuromuscular Diseases (2008–2020).